These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341 [TBL] [Abstract][Full Text] [Related]
23. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191 [TBL] [Abstract][Full Text] [Related]
24. Quantitative structure-based modeling applied to characterization and prediction of chemical toxicity. Benigni R; Richard AM Methods; 1998 Mar; 14(3):264-76. PubMed ID: 9571083 [TBL] [Abstract][Full Text] [Related]
25. Physiochemical drug properties associated with in vivo toxicological outcomes. Hughes JD; Blagg J; Price DA; Bailey S; Decrescenzo GA; Devraj RV; Ellsworth E; Fobian YM; Gibbs ME; Gilles RW; Greene N; Huang E; Krieger-Burke T; Loesel J; Wager T; Whiteley L; Zhang Y Bioorg Med Chem Lett; 2008 Sep; 18(17):4872-5. PubMed ID: 18691886 [TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730 [TBL] [Abstract][Full Text] [Related]
27. Global mapping of pharmacological space. Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068 [TBL] [Abstract][Full Text] [Related]
28. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta). Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacological and toxicological principles of research on drugs in man]. Gross F Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1619-25. PubMed ID: 4205542 [No Abstract] [Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
31. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Whitebread S; Hamon J; Bojanic D; Urban L Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262 [TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288 [TBL] [Abstract][Full Text] [Related]
33. Can we discover pharmacological promiscuity early in the drug discovery process? Peters JU; Hert J; Bissantz C; Hillebrecht A; Gerebtzoff G; Bendels S; Tillier F; Migeon J; Fischer H; Guba W; Kansy M Drug Discov Today; 2012 Apr; 17(7-8):325-35. PubMed ID: 22269136 [TBL] [Abstract][Full Text] [Related]
34. [Use of structure-activity analysis in toxicology]. Laass W Arch Exp Veterinarmed; 1978; 32(4):579-84. PubMed ID: 727870 [TBL] [Abstract][Full Text] [Related]
35. Toxicology and Carcinogenesis Studies of C.I. Acid Red 114 (CAS No. 6459-94-5) in F344/N Rats (Drinking Water Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1991 Dec; 405():1-236. PubMed ID: 12621513 [TBL] [Abstract][Full Text] [Related]
36. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status. Box RJ; Spielmann H Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470 [TBL] [Abstract][Full Text] [Related]
37. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology. Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955 [TBL] [Abstract][Full Text] [Related]
38. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity. Gravemann U; Volland J; Nau H Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366 [TBL] [Abstract][Full Text] [Related]
39. Chem-tox informatics: data mining using a medicinal chemistry building block approach. Johnson DE; Blower PE; Myatt GJ; Wolfgang GH Curr Opin Drug Discov Devel; 2001 Jan; 4(1):92-101. PubMed ID: 11727328 [TBL] [Abstract][Full Text] [Related]
40. [Characterization of drug, narcotic and psychotropic drug chirality by statistical methods]. Noszál B; Schiller Z Acta Pharm Hung; 1999 Apr; 69(2):85-90. PubMed ID: 10389303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]